{
    "root": "b8c1c31e-710f-4828-98ea-51f0a7818d43",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Tydemy",
    "value": "20250505",
    "ingredients": [],
    "indications": {
        "text": "tydemy combination drospirenone , progestin ethinyl estradiol , estrogen containing folate , indicated females reproductive potential : prevent pregnancy . ( 1.1 ) raise folate levels females reproductive potential choose oral contraceptive contraception . ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "take one tablet daily mouth time every day . ( 2.1 ) tablets must taken order directed blister pack . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tydemy ( drospirenone , ethinyl estradiol levomefolate calcium tablets levomefolate calcium tablets ) available blister pack containing 28 tablets packed pouch ( ndc 68180-904-71 ) . three pouches packaged carton ( ndc 68180-904-73 ) . blister contains 28 film-coated tablets following order : 21 orange , round shaped , biconvex film-coated tablets debossed `` lu `` one side `` j63 `` side containing 3 mg drospirenone , 0.03 mg ethinyl estradiol 0.451 mg levomefolate calcium . 7 light orange , round shaped , biconvex film-coated tablets debossed `` lu `` one side `` j62 `` side containing 0.451 mg levomefolate calcium .",
    "adverseReactions": "tydemy contraindicated females known develop following conditions : renal impairment adrenal insufficiency high risk arterial venous thrombotic diseases . examples include women known : smoke , age 35 [ boxed warning ( 5.1 ) ] deep vein thrombosis pulmonary embolism , past [ ( 5.1 ) ] cerebrovascular disease [ ( 5.1 ) ] coronary artery disease [ ( 5.1 ) ] thrombogenic valvular thrombogenic rhythm diseases heart ( example , subacute bacterial endocarditis valvular disease , atrial fibrillation ) [ ( 5.1 ) ] inherited acquired hypercoagulopathies [ ( 5.1 ) ] uncontrolled hypertension [ ( 5.6 ) ] diabetes mellitus vascular disease [ ( 5.8 ) ] headaches focal neurological symptoms migraine headaches without aura age 35 [ ( 5.9 ) ] undiagnosed abnormal uterine bleeding [ ( 5.10 ) ] current diagnosis , history , breast cancer , may hormone-sensitive [ ( 5.3 ) ] liver tumor ( benign malignant ) liver disease [ ( 5.4 ) ( 8.7 ) ] hepatitis c combinations containing ombitasvir/paritaprevir/ritonavir , without dasabuvir due potential alt elevations [ ( 5.5 ) ( 7.3 ) ] .",
    "indications_original": "Tydemy is a combination of drospirenone, a progestin and ethinyl estradiol, an estrogen containing a folate, indicated for use by females of reproductive potential to: Prevent pregnancy. ( 1.1 ) Raise folate levels in females of reproductive potential who choose to use an oral contraceptive for contraception. ( 1.2 )",
    "contraindications_original": "Take one tablet daily by mouth at the same time every day. ( 2.1 ) Tablets must be taken in the order directed on the blister pack. ( 2.1 )",
    "warningsAndPrecautions_original": "Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets) is available in blister pack containing 28 tablets packed in a pouch (NDC 68180-904-71). Such three pouches are packaged in a carton (NDC 68180-904-73). \n                        Each blister contains 28 film-coated tablets in the following order: \n                        \n                           21 orange, round shaped, biconvex film-coated tablets debossed with \"LU\" on one side and \"J63\" on other side each containing 3 mg drospirenone, 0.03 mg ethinyl estradiol and 0.451 mg levomefolate calcium.\n                           7 light orange, round shaped, biconvex film-coated tablets debossed with \"LU\" on one side and \"J62\" on other side each containing 0.451 mg levomefolate calcium.",
    "adverseReactions_original": "Tydemy is contraindicated in females who are known to have or develop the following conditions: \n                  \n                     Renal impairment\n                     Adrenal      insufficiency\n                     A high risk of arterial or      venous thrombotic diseases. Examples include women who are known to:\n                           Smoke,      if over age 35 [see Boxed Warning and Warnings and Precautions (5.1)] \n                           \n                           Have deep vein thrombosis or      pulmonary embolism, now or in the past [see Warnings and Precautions (5.1)] \n                           \n                           Have cerebrovascular disease [see      Warnings and Precautions (5.1)] \n                           \n                           Have coronary artery disease [see Warnings and Precautions (5.1)] \n                           \n                           Have      thrombogenic valvular or thrombogenic rhythm diseases of the heart (for      example, subacute bacterial endocarditis with valvular disease, or atrial      fibrillation) [see Warnings and Precautions (5.1)] \n                           \n                           Have inherited or acquired      hypercoagulopathies [see Warnings and Precautions (5.1)]\n                           \n                           Have      uncontrolled hypertension [see Warnings and Precautions (5.6)] \n                           \n                           Have diabetes mellitus with      vascular disease [see Warnings and Precautions (5.8)] \n                           \n                           Have headaches with focal      neurological symptoms or have migraine headaches with or without aura if over age 35 [see Warnings      and Precautions (5.9)] \n                           \n                        \n                     \n                     Undiagnosed abnormal uterine bleeding [see Warnings and Precautions (5.10)]\n                     \n                     Current diagnosis of, or      history of, breast cancer, which may be hormone-sensitive [see      Warnings and Precautions (5.3)] \n                     \n                     Liver tumor (benign or malignant) or liver disease [see Warnings and      Precautions (5.4) and Use in Specific Populations      (8.7)] \n                     \n                     Use of Hepatitis C drug combinations containing      ombitasvir/paritaprevir/ritonavir, with or without dasabuvir due to the      potential for ALT elevations [see Warnings and Precautions (5.5)      and Drug Interactions (7.3)].",
    "drug": [
        {
            "name": "Tydemy"
        }
    ]
}